Poster Listing

Poster Number Presenter Paper Title Theme Abstract
001 Elisa Al-hakim FORMATIVE RESEARCH WITH IMPACTED POPULATIONS TO INFORM HCV PROGRAM FOR PEOPLE WHO INJECT DRUGS (PWID) Epidemiology and Public Health Research Abstract
002 Afia Amoako KNOWLEDGE SYNTHESIS OF PATIENT AND PROVIDER PERCEIVED BARRIERS AND FACILITATORS TO HEPATITIS C (HCV) TREATMENT AMONG HUMAN IMMUNODEFICIENCY VIRUS (HIV) COINFECTED POPULATIONS IN CANADA Epidemiology and Public Health Research Abstract
003 Megan Bardsley HEPATITIS C TESTING AND ACCESS TO CARE AMONG PEOPLE WHO INJECT PSYCHOACTIVE DRUGS IN ENGLAND, WALES AND NORTHERN IRELAND: INSIGHTS FROM 2017 NATIONAL SURVEY DATA. Epidemiology and Public Health Research Abstract
004 Megan Bardsley THE ASSOCIATION BETWEEN HOMELESSNESS AND HEPATITIS C EXPOSURE AMONG 11,101 PEOPLE WHO INJECT DRUGS IN ENGLAND, WALES AND NORTHERN IRELAND: A CROSS-SECTIONAL STUDY Epidemiology and Public Health Research Abstract
005 Tyler Bartholomew BASELINE PREVALENCE AND PREDICTORS OF HIV/HCV INFECTION AMONG PERSONS WHO INJECT DRUGS ACCESSING A SYRINGE SERVICES PROGRAM; MIAMI, FL Epidemiology and Public Health Research Abstract
006 Tyler Bartholomew INJECTION DRUG USE, INJECTION RISK AND HIV/HCV STATUS AMONG PEOPLE ACCESSING A SYRINGE SERVICE PROGRAM; A LATENT CLASS ANALYSIS Epidemiology and Public Health Research Abstract
007 Sofia Bartlett INCONSISTENCIES IN METHODOLOGY, REPORTING, AND SUBJECTIVE DESCRIPTION OF HEPATITIS C VIRUS REINFECTION RATES AMONG PEOPLE WHO INJECT DRUGS: POTENTIAL CONTRIBUTION TO STIGMA AND DISCRIMINATION? Epidemiology and Public Health Research Abstract
008 Katie Burk BARRIERS AND FACILITATORS TO HEPATITIS C TREATMENT USING DIRECTOR ACTING ANTIVIRALS AMONG PEOPLE WHO INJECT DRUGS IN SAN FRANCISCO, CALIFORNIA Epidemiology and Public Health Research Abstract
009 Maia Butsashvili BARRIERS OF LINKAGE TO HEPATITIS C CARE AMONG PEOPLE WHO INJECT DRUGS IN GEORGIA Epidemiology and Public Health Research Abstract
010 Athina Chounta STUDY OF COMPLIANCE IN IV DRUG USERS WITH HEPATITIS C. 10 YEARS FOLLOW UP DATA FROM A UNIVERSITY HOSPITAL IN GREECE. Epidemiology and Public Health Research Abstract
011 Karli Hochstatter DETECTING HEPATITIS C VIRUS TRANSMISSION CLUSTERS USING REMNANT SERUM SPECIMENS FROM KEY AFFECTED POPULATIONS TESTED IN PUBLIC HEALTH SETTINGS Epidemiology and Public Health Research Abstract
012 Zahid Butt GEOGRAPHIC CASCADE OF HCV CARE: A TOOL FOR TARGETED INTERVENTIONS AND PROGRAM EVALUATION Epidemiology and Public Health Research Abstract
013 Beth Catlett EVALUATION OF HCV RNA TESTING FROM FINGER-STICK CAPILLARY DRIED BLOOD SPOT AND VENEPUNTURE-COLLECTED SAMPLES: A COHORT STUDY Epidemiology and Public Health Research Abstract
014 Lara Marquez WHAT IS THE OPTIMAL HCV ELIMINATION STRATEGY AMONG PWID IN A MIDDLE-INCOME, HIGH BURDEN SETTING? A MODELING AND ECONOMIC ANALYSIS IN TIJUANA, MEXICO Epidemiology and Public Health Research Abstract
015 Bridget Draper COMMUNITY-BASED POINT-OF-CARE TESTING AND TREATMENT FOR PEOPLE WHO INJECT DRUGS IN MYANMAR Epidemiology and Public Health Research Abstract
016 Peter Collin CHRONIC MEDICAL DISEASES AND HEALTHCARE UTILIZATION IN PEOPLE WHO CURRENTLY INJECT DRUGS (PCID) WITH HEPATITIS C (HCV) IN NEW YORK CITY Epidemiology and Public Health Research Abstract
017 Jeffrey Craig UTILIZATION OF POINT OF CARE HEPATITIS C TESTING ON PRIORITY POPULATIONS IN AN OUTREACH SETTING Epidemiology and Public Health Research Abstract
018 Olanrewaju Onigbogi WILLINGNESS TO ACCESS COMMUNITY-BASED HEPATITIS C AND HIV TESTING CENTRES AMONG INJECTING DRUG USERS IN LAGOS NIGERIA Epidemiology and Public Health Research Abstract
019 Joseph Doyle HEPATITIS B IMMUNITY AND SUSCEPTABILITY AMONG PEOPLE LIVING WITH HIV AND HEPATITIS C CO-INFECTION IN MELBOURNE, AUSTRALIA Epidemiology and Public Health Research Abstract
020 Joseph Doyle RISK BEHAVIOURS FOLLOWING HEPATITIS C TREATMENT AMONG GAY AND BISEXUAL MEN LIVING WITH HIV IN MELBOURNE, AUSTRALIA Epidemiology and Public Health Research Abstract
021 Elizabeth Crock TOWARDS OPTIMISING CARE AND PREVENTION FOR PEOPLE WHO INJECT DRUGS, AND LIVING WITH HIV AND VIRAL HEPATITIS IN MELBOURNE, AUSTRALIA - EVALUATION OF AN INTEGRATED HIV AND HOMELESSNESS NURSING SERVICE Epidemiology and Public Health Research Abstract
022 Rimunchung Duroi Chongdur A NETWORK OF PEOPLE WHO INJECT DRUGS SUCCESSFULLY PRODUCED A STATE WIDE AUTHENTICATED HCV PREVALENCE DATA AMONG PWIDS AND THEIR SPOUSES. PERHAPS, STILL THE ONLY STATE DATA EVER PRODUCED. Epidemiology and Public Health Research Abstract
023 Ragnheidur Fridriksdottir RE-ENGAGEMENT IN CARE FOR HEPATITIS C IN THE TRAP HEPC PROGRAM: EVERY PATIENT DESERVES A SECOND CHANCE. Epidemiology and Public Health Research Abstract
024 Ed Hall HEPATITIS C SCREENING AND TREATMENT WITHIN AN OPIOID TREATMENT PROGRAM: CURRENT CHALLENGES AND POTENTIAL SOLUTIONS Epidemiology and Public Health Research Abstract
025 Paul Harkin INTEGRATED HARM REDUCTION PROGRAMMING: SYRINGE SERVICE PROGRAMS AND HIV/HCV TESTING Epidemiology and Public Health Research Abstract
026 Emmanuelle Huchet DISPARITY AMONG MARGINALIZED PATIENTS IN THE HEPATITIS C CASCADE OF CARE IN A SPECIALIZED CLINIC? Epidemiology and Public Health Research Abstract
027 Brendan Jacka SHORT-TERM ‘CHEQUE EFFECTS’ ON DRUG CONSUMPTION BEHAVIOUR AND THEIR ASSOCIATION WITH DETERMINANTS OF HCV RISK AMONG PEOPLE WHO INJECT DRUGS Epidemiology and Public Health Research Abstract
028 Naveed Janjua ASSOCIATION BETWEEN PRESCRIPTION OPIOIDS AND HEPATITIS C VIRUS SEROCONVERSION AMONG PEOPLE WHO USE INJECTION DRUGS IN BRITISH COLUMBIA Epidemiology and Public Health Research Abstract
029 Amy Jessop PILOT TESTING “TAKE CHARGE, GET CURED” WITH METHADONE PATIENTS: A MHEALTH TOOL ADDRESSING HCV TREATMENT INITIATION Epidemiology and Public Health Research Abstract
030 Mohammed Abul Kalam RISKY BEHAVIOR AND HIV/HCV KNOWLEDGE OF WOMEN COMMERCIAL SEX WORKERS (WCSWs) AND INJECTING DRUG USERS (IDUs) IN RAJSHAHI CITY OF BANGLADESH Epidemiology and Public Health Research Abstract
031 Shashi Kapadia INCREASING NUMBER OF PROVIDERS TREATING HEPATITIS C AFTER DIRECT ACTING ANTIVIRALS IN THE UNITED STATES: IMPLICATIONS FOR TREATMENT ACCESS. Epidemiology and Public Health Research Abstract
032 Andreas Kapatais HIV-PERCENTAGE OF ALL TYPES OF HEPATITIS VIRUS IN IVDU USERS AMONG THE POPULATION OF HELLAS Epidemiology and Public Health Research Abstract
033 Andreas Kapatais CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF CHC ACCESS TO TREATMENT WITH DAAs Epidemiology and Public Health Research Abstract
034 Jacob Ziff PREDICTORS OF HEPATITIS C VIRUS TREATMENT OUTCOMES IN A HARM REDUCTION-FOCUSED PRIMARY CARE PROGRAM IN NEW YORK CITY Clinical Research Abstract
035 Imtiaz Alam IMPROVING PWID HEPATITIS C CARE CASCADE THROUGH ELECTRONIC HEALTH ENGAGEMENT Clinical Research Abstract
036 Olga Anagnostou EXTENDING THE CRITERIA FOR CHRONIC HEPATITIS C (CHC) TREATMENT WITH DIRECT ACTING ANTIVIRALS (DAAS) IN GREECE: BEST BENEFIT IN LINKAGE TO CARE FOR PATIENTS WHO INJECT DRUGS (PWID’S) Clinical Research Abstract
037 Olga Anagnostou HCV MICRO ELIMINATION IN A REAL WORLD SETTING AT SUBSTITUTION PROGRAMS IN ATHENS, GREECE Clinical Research Abstract
038 Yesenia Aponte-Melendez HEALTH CARE RELATED STIGMA AMONG PEOPLE WHO INJECT DRUGS IN NEW YORK CITY Clinical Research Abstract
039 Danielle Back BARRIERS TO HEPATITIS C TREATMENT PERSIST FROM THE INTERFERON-ERA Clinical Research Abstract
040 Sahar Bajis HEPATITIS C VIRUS TESTING, LIVER DISEASE ASSESSMENT AND TREATMENT UPTAKE AMONG PEOPLE WHO INJECT DRUGS PRE- AND POST-UNIVERSAL ACCESS TO DIRECT-ACTING ANTIVIRAL TREATMENT IN AUSTRALIA: THE LIVERLIFE STUDY Clinical Research Abstract
041 Lewis Beer SVR12 OUTCOMES IN CHRONIC HCV INFECTED PWID WHO ARE NON-COMPLIANT WITH RECOMMENDED TREATMENT REGIMENS Clinical Research Abstract
042 Lewis Beer DOES INJECTING BEHAVIOUR CHANGE FOLLOWING DIRECT ACTING ANTIVIRAL HEPATITIS C THERAPY IN PERSONS WHO INJECT DRUGS ? Clinical Research Abstract
043 Jasna Cernosa SUSTAINED VIROLOGICAL RESPONSE TO HCV TREATMENT WITH DIRECT-ACTING ANTIVIRALS IN PEOPLE WHO INJECT DRUGS (PWID) AND NON-PWID: RESULTS OF A NATIONAL COMPARATIVE SURVEY IN SLOVENIA Clinical Research Abstract
044 Brian Conway CHARACTERIZATION OF PATIENTS IN CANADA WITH CHRONIC HCV INFECTION INITIATING DAA THERAPY BASED ON RISK FOR HCV TRANSMISSION AND RESPONSE TO TREATMENT: THE REAL-WORLD C-RESPECT STUDY Clinical Research Abstract
045 Brian Conway REAL-WORLD EFFICACY OF SALVAGE THERAPIES FOR THE TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION IN TREATMENT EXPERIENCED PEOPLE WHO INJECT DRUGS (PWID) Clinical Research Abstract
046 Jason Edwards IDENTIFICATION OF HCV AND LINKAGE TO CARE FROM A DETOXIFICATION UNIT – A NOVEL STRATEGY FOR HCV MICRO-ELIMINATION 431 Clinical Research Abstract
047 Scott Fenwick SPONTANEOUS CLEARANCE OF HEPATITIS C VIRUS IN A COHORT OF PATIENTS ENROLLED IN A HARM REDUCTION CLINIC IN NEW BRUNSWICK, CANADA: 2014-2018 Clinical Research Abstract
048 Urmo Jaanimägi INFLUENCE OF SOCIAL DETERMINANTS OF HEALTH AND SUBSTANCE USE CHARACTERISTICS ON PERSONS WHO USE DRUGS PURSUIT OF CARE FOR HEPATITIS C VIRUS INFECTION Clinical Research Abstract
049 Robin Jindal HCV TREATMENT ADHERENCE AMONG PEOPLE WHO INJECT DRUGS (PWID) Clinical Research Abstract
050 Martin Kåberg REAL-WORLD TREATMENT DATA FROM A NEEDLE EXCHANGE WITH A HIGH PREVALENCE OF HCV AND AMPHETAMINE USE Clinical Research Abstract
051 Shashi Kapadia HCV SEEK, TEST, AND RAPID-TREATMENT (HCV-ST&RT) FOR YOUNG PEOPLE WHO INJECT DRUGS WITH HEPATITIS C– DESCRIPTION OF MODEL AND BASELINE CHARACTERISTICS. Clinical Research Abstract
052 Tianna Magel HCV AMONG CIRRHOTIC PEOPLE WHO USE/INJECT DRUGS (PWID): RESPONSE TO THERAPY AND LONG-TERM FOLLOW-UP Clinical Research Abstract
053 Tianna Magel MULTIDISCIPLINARY CARE AND THE FOUR-LEGGED CHAIR: THE ADDICTION LEG Clinical Research Abstract
054 Tianna Magel MORBIDITY AND MORTALITY IN HCV-INFECTED PEOPLE WHO USE DRUGS (PWUD): BEYOND THE SVR12 Clinical Research Abstract
055 Valérie Martel-laferrière EFFECT OF A SINGLE-DAY INVESTIGATION FOR HCV INFECTION ON TREATMENT INITIATION AMONG PWID, BEFORE AND AFTER UNIVERSAL ACCESS TO DIRECT ACTING ANTIVIRALS Clinical Research Abstract
056 Sarah Kattakuzhy HCV REINFECTION NOT ASSOCIATED WITH OAT ENGAGEMENT, DRUG USE, OR SEXUAL RISK IN PERSONS WITH OPIOID USE DISORDER AND INJECTION DRUG USE: DATA FROM THE ANCHOR STUDY Clinical Research Abstract
057 Kate Mason FEASIBILITY OF RAPID HEPATITIS C POINT-OF-CARE RNA TESTING AND TREATMENT AT AN INTEGRATED SUPERVISED CONSUMPTION SITE IN TORONTO, CANADA Clinical Research Abstract
058 Christian Sharkey WORKING TOWARDS MICRO-ELIMINATION OF HCV IN PWID. A DIRECT OBSERVED THERAPY VS FORTNIGHTLY COLLECTION STUDY FOR HCV TREATMENT – ADVANCE HCV STUDY Clinical Research Abstract
059 Jeffrey Weiss RANDOMIZED CLINICAL TRIAL TO TEST E-HEALTH INTERVENTIONS TO IMPROVE ADHERENCE TO A ONCE-DAILY SINGLE-TABLET REGIMEN IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION Clinical Research Abstract
060 Vincenzo Messina AN INNOVATIVE MODEL FOR LINKAGE TO CARE OF PWID WITH HCV INFECTION IN ITALY Clinical Research Abstract
061 Brianna Norton DRUG USER HEALTHCARE DELIVERED ONSITE AT A SYRINGE EXCHANGE: HCV, MAT, AND PREP Clinical Research Abstract
062 Anne Øvrehus RISK BEHAVIOURS AND PREVALENCE OF BLOOD BORNE INFECTIONS IN YOUNG PEOPLE SEEKING TREATMENT OR ADVICE FOR DRUG USE – THE POTENTIAL OF DRIED BLOOD SPOTS. Clinical Research Abstract
063 Anne Øvrehus PATIENT REPORTED EXPERIENCE AND OUTCOME OF HEPATITIS C TREATMENT IN PEOPLE WHO INJECT DRUGS OR RECEIVING OPIATE SUBSTITUTION THERAPY. A PEER INITIATED SURVEY IN DENMARK. Clinical Research Abstract
064 Irene Pericot-Valverde PATTERNS AND CORRELATES OF CIGARETTE SMOKING AMONG PEOPLE WHO INJECT DRUGS RECEIVING TREATMENT FOR HEPATITIS C Clinical Research Abstract
065 Phillip Read THE CHALLENGE OF FOLLOW-UP: HEPATOCELLULAR CARCINOMA SURVEILLANCE IN MARGINALIZED PATIENTS WITH CIRRHOSIS TREATED FOR HCV IN A LOW THRESHOLD PRIMARY HEALTH CARE SETTING Clinical Research Abstract
066 Emma Robinson EVALUATING TREATMENT AS PREVENTION AMONG PEOPLE WHO INJECT DRUGS IN DUNDEE FOR HCV (ERAPID-HCV) Clinical Research Abstract
067 Elana Rosenthal HIGH UPTAKE OF COLLOCATED OPIOID AGONIST THERAPY WITH DAA IS ASSOCIATED WITH REDUCED RISKS AND IMPROVED SVR IN PEOPLE WITH ACTIVE INJECTION DRUG USE: DATA FROM THE ANCHOR STUDY Clinical Research Abstract
068 Raphael Schubert INTERIM RESULTS OF AN ONGOING PROJECT TO ELIMINATE CHRONIC HEPATITIS C IN PWID WITH ONGOING INTRAVENOUS DRUG USE AND A HIGH RISK OF NON-ADHERENCE TO DIRECT-ACTING ANTIVIRALS IN VIENNA Clinical Research Abstract
069 Raphael Schubert INTERIM RESULTS OF AN AUSTRIAN HCV-MICROELIMINATION PROJECT TO INCREASE SCREENING AND LINKAGE TO CARE IN PWID IN VIENNA Clinical Research Abstract
070 Andrew Seaman A NOVEL HEPATITIS C MICRO-ELIMINATION MODEL IN A LARGE HEALTHCARE FOR THE HOMELESS ORGANIZATION Clinical Research Abstract
071 Omar Sims TIME TO TREATMENT DISFAVORS HCV PATIENTS WITH HIV CO-INFECTION Clinical Research Abstract
072 Omar Sims PREVALENCE OF ALCOHOL AND SUBSTANCE USE IN HIV/HCV CO-INFECTED PATIENTS RECEIVING ANTIRETROVIRALS Clinical Research Abstract
073 Jan Tait THE ROAD TO HEPATITIS C VIRUS (HCV) ELIMINATION: RE-INFECTIONS AFTER SUSTAINED VIRAL RESPONSE (SVR), WHY WE MUST RETEST AND OFFER RETREATMENT Clinical Research Abstract
074 Clara Thierfelder VERY LATE RELAPSE OF CHRONIC HEPATITIS C TREATED WITH LDV/SOF Clinical Research Abstract
075 Gunnar Thingnes CHALLENGES IN DELIVERY OF POINT OF CARE TESTING FOR HCV RNA IN A MOBILE HEALTH SERVICE FOR PEOPLE WHO INJECT DRUGS (PWID) Clinical Research Abstract
076 Effrosyni Tsirogianni HCV MICROELIMINATION ΕNHANCED BY A NETWORK CONNECTING ALL DETOXIFICATION AND SUBSTITUTION PROGRAMS WITH AN EXPERTIZED HEPATOLOGY CLINIC IN NORTHEN GREECE Clinical Research Abstract
077 Jorge Valencia RECENT ABSTINENCE AT THE MOMENT TO INITIATE HCV TREATMENT IS NO GUARANTEE TO AVOID HCV REINFECTIONS Clinical Research Abstract
078 Tatiana Vera FACTORS CONTRIBUTING TO HCV TREATMENT FAILURE AND SUCCESSFUL RETREATMENT IN PEOPLE WHO USE DRUGS Clinical Research Abstract
079 Shaokun Liu FACTORS ASSOCIATED WITH THE IMPROVEMENT OF FAMILY RELATIONSHIPS AMONG METHADONE MAINTENANCE TREATMENT CLIENTS: A LONGITUDINAL ANALYSIS OF REGISTER DATA FROM 15 CLINICS IN GUANGDONG, CHINA Epidemiology and Public Health Research Abstract
080 Marina Kornilova FACTORS ASSOCIATED WITH OVERDOSE AMONG PEOPLE WHO INJECT DRUGS IN UKRAINE Epidemiology and Public Health Research Abstract
081 Marina Kornilova THE SEXUAL PARTNERS OF PEOPLE WHO INJECT DRUGS IN UKRAINE IS THE NEXT TARGET OF THE HIV EPIDEMIC IF NO PREVENTION APPLIED Epidemiology and Public Health Research Abstract
082 Cheap FohLow MOST AT RISK POPULATIONS AND HEALTHCARE WORKERS PERSPECTIVES ON EXISTING SERVICES FOR HEPATITIS C CARE AND SUPPORT IN MALAYSIA Epidemiology and Public Health Research Abstract
083 Qian Lu DEFINING DOSING-RELATED TAPERING CHARACTERISTICS TO DECREASE CONCURRENT HEROIN USE: A RETROSPECTIVE COHORT STUDY OF METHADONE MAINTENANCE TREATMENT PARTICIPANTS IN GUANGDONG, CHINA Epidemiology and Public Health Research Abstract
084 Amy Malaguti PSYCHOSOCIAL PREDICTORS OF RISK OF HEPATITIS C (HCV) REINFECTION IN PEOPLE WHO INJECT DRUGS ON HCV TREATMENT. Epidemiology and Public Health Research Abstract
085 Francesco Manca NOVEL HCV SCREENING STRATEGIES FOR HARD TO REACH POPULATIONS: ARE THEY COST-EFFECTIVE? Epidemiology and Public Health Research Abstract
086 Madeleine Caven HCV DIAGNOSIS AND TREATMENT, IMPACT OF KNOWLEDGE OF HCV STATUS ON BEHAVIOUR OF PEOPLE WHO INJECT DRUGS, A SERVICE EVALUATION, THE HOOKED C PROJECT Epidemiology and Public Health Research Abstract
087 Natasha Martin COST-EFFECTIVENESS OF UNIVERSAL HEPATITIS C VIRUS SCREENING OF PREGNANT WOMEN IN THE UNITED STATES Epidemiology and Public Health Research Abstract
088 Stefanie Materniak FINDING THE STARTING POINT TOWARD HEPATITIS C ELIMINATION: IDENTIFYING KNOWN PREVALENT HEPATITIS C CASES IN SOUTHERN NEW BRUNSWICK, CANADA Epidemiology and Public Health Research Abstract
089 Catharina Matheï HEPATITIS C RELATED MORTALITY IN A COHORT OF DRUG USERS IN FLANDERS Epidemiology and Public Health Research Abstract
090 April Mazzuca THE CEDAR HCV BLANKET PROGRAM: BARRIERS AND FACILITATORS OF HEPATITIS C TREATMENT UPTAKE AMONG INDIGENOUS PEOPLE WHO USE DRUGS IN BC, CANADA. Epidemiology and Public Health Research Abstract
091 Miranda Moore USING HEPATITIS C SURVEILLANCE DATA TO PROFILE HEPATITIS C CARE AT SUBSTANCE USE TREATMENT FACILITIES, NEW YORK CITY, 2017–2018 Epidemiology and Public Health Research Abstract
092 Alberto Moriggia AGEING WITH ADDICTION: DESCRIBING HEALTH CONDITIONS OF YOUNGER AND OLDER DRUG USERS IN SWITZERLAND Epidemiology and Public Health Research Abstract
093 Margaret O'sullivan PROJECT ITTREAT (INTEGRATED COMMUNITY BASED TEST – STAGE-TREAT HCV SERVICE) FOR PEOPLE WHO INJECT DRUGS: CLINICAL, PATIENT REPORTED AND HEALTH ECONOMIC OUTCOMES. Epidemiology and Public Health Research Abstract
094 Camila A Picchio LATE PRESENTATION OF CHRONIC HEPATITIS B AND C VIRUS IN PEOPLE WHO INJECT DRUGS IN SPAIN DESPITE UNRESTRICTED ACCESS TO HBV AND HCV THERAPY Epidemiology and Public Health Research Abstract
095 Alisa Pedrana THE IMPACT OF COMMUNITY-BASED RAPID POINT-OF-CARE TESTING ON ENHANCING UPTAKE OF HEPATITIS C TREATMENT FOR PEOPLE WHO INJECT DRUGS IN NEEDLE AND SYRINGE SERVICES. Epidemiology and Public Health Research Abstract
096 Alisa Pedrana A GLOBAL INVESTMENT FRAMEWORK FOR HEPATITIS C ELIMINATION Epidemiology and Public Health Research Abstract
097 Alisa Pedrana HEPATITIS C ANTIBODY TESTING TREND PRE AND POST UNIVERSAL ACCESS TO DIRECT ACTING ANTIVIRALS IN AUSTRALIA: SEGMENTED REGRESSION OF PRIMARY CARE CLINIC DATA. Epidemiology and Public Health Research Abstract
098 Christian Ramers DRUG USE HABITS, OVERDOSE EXPERIENCE, AND INFECTIOUS DISEASE RISK BEHAVIORS AMONG PARTICIPANTS IN AN URBAN SYRINGE EXCHANGE PROGRAM Epidemiology and Public Health Research Abstract
099 Phillip Read WHEN TREATMENT ACCESS DOES NOT EQUAL TREATMENT INITIATION: AN ANALYSIS OF CLIENTS WHO DO NOT INITIATE DIRECT ACTING ANTIVIRALS Epidemiology and Public Health Research Abstract
100 Eli Rosenberg A STANDARDIZATION MODEL FOR ESTIMATING POPULATIONS OF PERSONS WHO INJECT DRUGS IN US STATES, 2017 Epidemiology and Public Health Research Abstract
101 Andrew Scheibe HEPATITIS C AND HIV CO-INFECTION AMONG PEOPLE WHO USE DRUGS AND OTHER KEY POPULATIONS IN SOUTH AFRICA: FINDINGS FROM A SEVEN-CITY CROSS-SECTIONAL SURVEY Epidemiology and Public Health Research Abstract
102 Nick Scott UPSCALING PREVENTION, TESTING AND TREATMENT TO CONTROL HEPATITIS C AS A PUBLIC HEALTH THREAT IN DAR ES SALAAM, TANZANIA Epidemiology and Public Health Research Abstract
103 Nick Scott A GLOBAL INVESTMENT CASE FOR HEPATITIS C Epidemiology and Public Health Research Abstract
104 Sanjeev Sirpal BARRIERS TO HEPATITIS C DIAGNOSIS AND TREATMENT IN THE DAA ERA: REVIEW OF THE LITERATURE AND RESULTS OF A COMMUNITY-BASED SURVEY OF PRIMARY CARE PRACTITIONERS Epidemiology and Public Health Research Abstract
105 Kathryn Snow SUBSTANCE USE, MENTAL HEALTH, AND HEALTHCARE COSTS AFTER RELEASE FROM AUSTRALIAN PRISONS Epidemiology and Public Health Research Abstract
106 Kwame Thompson SPONTANEOUS REMISSION IN HCV-EXPOSED AFRICAN-AMERICAN AND HISPANIC IV DRUG USERS TESTED IN 2018-2019 Epidemiology and Public Health Research Abstract
107 Kirsten Trayner RAISED RISK OF BLOOD BORNE VIRUS INFECTION AND OTHER DRUG RELATED HARMS AMONG PEOPLE WHO INJECT DRUGS IN PUBLIC PLACES Epidemiology and Public Health Research Abstract
108 Jorge Valencia HCV INFECTION RISK AND GENDER VULNERABILITY OF WOMEN WHO INJECT DRUGS. Epidemiology and Public Health Research Abstract
109 Cristina Valente CURRENT PRACTICES OF SCREENING HEPATITIS C INFECTION IN AN INTEGRATED RESPONSE CENTER FOR ADDITIVE AND DEPENDENCE BEHAVIOURS Epidemiology and Public Health Research Abstract
110 Aaron Vanderhoff ASSESSMENT OF HEPATITIS C SCREENING STRATEGIES IN DIFFERENT COMMUNITY SETTINGS IN A CANADIAN METROPOLITAN AREA Epidemiology and Public Health Research Abstract
111 Paul Haber OVERCOMING INSTITUTIONAL BARRIERS TO INTEGRATED CARE: LINKAGE TO HEPATITIS C TREATMENT IN THE OPIOID AGONIST TREATMENT SETTING Social Science and Policy Research Abstract
112 Darcy Bowman BEYOND CLINICAL OUTCOMES: IMPACT AND WIDER SOCIAL AND HEALTHCARE SYSTEM IMPLICATIONS OF HEPATITIS C VIRUS (HCV) TREATMENT AND CURE Social Science and Policy Research Abstract
113 Susan Chong HEPATITIS C TREATMENT: PEER INSIGHTS TO UNDERSTANDING ENABLERS AND IMPEDIMENTS TO DAA UPTAKE AMONG PEOPLE WHO INJECT DRUGS Social Science and Policy Research Abstract
114 Tianna Magel LOW LEVELS OF HCV KNOWLEDGE IN KEY POPULATIONS: A BARRIER TO HCV ELIMINATION188 Social Science and Policy Research Abstract
115 Alberto Moriggia EDUCATION ON ADDICTION MEDICINE IN THE BASIC HEALTH CARE TRAINING: THE EXPERIENCE OF SWITZERLAND Social Science and Policy Research Abstract
116 Marie Jauffret-Roustide HCV CRISIS AMONG RUSSIAN-SPEAKING INJECTING DRUG USERS IN FRANCE: THE URGENT NEED TO IMPROVE ACCESS TO CARE AND SOCIAL INTEGRATION Social Science and Policy Research Abstract
117 George Kalamitsis FACTORS ASSOCIATED WITH LOW RATES OF ENGAGEMENT IN OPIOID SUBSTITUTION TREATMENT AMONG PEOPLE WHO USE DRUGS IN ATHENS Social Science and Policy Research Abstract
118 Naren Nallapeta HCV MICROELIMINATION - IMPLEMENTATION OF THE INTERNIST-ADDICTION MEDICINE-HEPATOLOGY COLOCALIAZATION (IAHC) MODEL Social Science and Policy Research Abstract
119 Elana Rosenthal IF WE BUILD IT, WILL THEY COME? HIGH INTEREST IN SIF AMONG PWID WITH HCV IN WASHINGTON, DC Social Science and Policy Research Abstract
120 Adam Palayew THE IMPLEMENTATION OF HARM REDUCTION AND HEPATITIS C SERVICES FOR PEOPLE WHO INJECT DRUGS IN EUROPE: RESULTS FROM THE 2018 HEP-CORE SURVEY Social Science and Policy Research Abstract
121 Bruce Schackman COST OF HEPATITIS C CARE FACILITATION FOR HIV/HEPATITIS C CO-INFECTED PEOPLE WHO USE SUBSTANCES Social Science and Policy Research Abstract
122 Bernice Thompson STAMSH SLHANAY LLHWAT – WARRIOR WOMEN HEALING Social Science and Policy Research Abstract
123 Zoe Ward A COST-EFFECTIVENESS ANALYSIS OF AN INTERVENTION TO INCREASE LINKAGE TO CARE OF HCV-INFECTED PATIENTS ON OPIOID SUBSTITUTION THERAPY (HEPLINK IRELAND) Epidemiology and Public Health Research Abstract
124 Jack Williams A THRESHOLD ANALYSIS OF THE COST-EFFECTIVENESS OF HEPATITIS C TESTING IN EMERGENCY DEPARTMENTS IN THE U Epidemiology and Public Health Research Abstract
125 Hannah Zellman HEPATITIS C PREVALENCE AND RISK FACTORS AMONG PEOPLE WHO ENGAGE IN TRANSACTIONAL SEX WORK, PHILADELPHIA. Epidemiology and Public Health Research Abstract
126 Hannah Zellman HEALTH CARE ACCESS AMONG DRUG USERS IN PHILADELPHIA Epidemiology and Public Health Research Abstract
127 Mark Cassell IMPROVED LINKAGE TO HEPATITIS C ASSESSMENT AND TREATMENT WITHIN COMMUNITY DRUG SERVICES THROUGH COMBINED HEPATITIS C AND OPIATE SUBSTITUTION TREATMENT PRESCRIPTION APPOINTMENTS Models of Care Abstract
128 Sarah Donaldson “ASK A FRIEND” IDENTIFYING THE HIDDEN POPULATION: FORMER INTRAVENOUS DRUG USERS WHO ARE NO LONGER IN CONTACT WITH SERVICES. A RESPONDENT DRIVEN SAMPLING PROTOCOL. Models of Care Abstract
129 Monty Ghosh SEAMLESS INTEGRATION OF HEPATITIS C TREATMENT WITHIN AN INTRAVENOUS (IV) HYDROMORPHONE OPIOID AGONIST TREATMENT (IOAT) PROGRAM. Models of Care Abstract
130 Pamela Lynch RURAL US DRUG USER HEALTH THROUGH SYRINGE ACCESS PROGRAMMING Models of Care Abstract
131 Megan Stephen COLLABORATIVE WORKING WITH COMMUNITY PHARMACIES INCREASES TESTING AND ENHANCES ACCESS TO DIRECT ACTING ANTIVIRAL (DAA) THERAPY FOR HEPATITIS C (HCV) Models of Care Abstract
132 Phillip Read IMPROVING SVR12 FOLLOW-UP IN PRIMARY CARE WITH A STRUCTURED HEPATITIS C ASSESSMENT TOOL Models of Care Abstract
133 Sara Alsterberg HEPATITIS C TREATMENT AT A SWEDISH NEEDLE EXCHANGE PROGRAM: A SUCCESSFUL FULL-SERVICE MODEL FOR REACHING ACTIVE INJECTORS Models of Care Abstract
134 Andreea Adelina Artenie THE ST LUC COHORT: A LONGITUDINAL STUDY SERVING AS A STEPPING STONE TO HCV TREATMENT INITIATION AMONG PEOPLE WHO INJECT DRUGS Models of Care Abstract
135 Amélie Bédard IMPLEMENTATION OF A MODEL OF CARE FOR THE SCREENING AND TREATMENT OF HEPATITIS C IN THE OBEDJIWAN INDIGENOUS COMMUNITY WITH THE GOAL OF ELIMINATION Models of Care Abstract
136 Angelica Bedrosian HEPATITIS C CARE, OPIOID USE DISORDER TREATMENT, AND SYRINGE SERVICE PROGRAMMING: AN INTEGRATED APPROACH Models of Care Abstract
137 Lynne Biggart USING POINT OF CARE TESTING, SIMPLIFIED ASSESSMENT AND MONITORING AND NURSE/PHARMACIST/ADDICTIONS OFFICER INITIATION OF TREATMENT: RESULTS FROM PHASE 1 OF THE SPRINGBURN MICROELIMINATION PROJECT. Models of Care Abstract
138 Hugo Bissonnet INTEGRATED APPROACH TO COMMUNITY-BASED DRUG TESTING (IACBDT) IN THE LAURENTIANS IN QUEBEC TO PREVENT DEATHS FROM OPIOID OVERDOSES Models of Care Abstract
139 Matthew Bonn PALS: LENDING A HAND TO PEOPLE WHO USE SUBSTANCES TRANSITIONING OUT OF CENTRAL NOVA SCOTIA (CANADA) CORRECTIONAL FACILITY Models of Care Abstract
140 Matthew Bonn HEPNS: CURBING HEPATITIS C TRANSMISSION THROUGH EFFECTIVE LINKAGE OF PEOPLE WHO INJECT SUBSTANCES TO TREATMENT IN NOVA SCOTIA, CANADA Models of Care Abstract
141 Stefan Bourgeois LINKAGE TO CARE: ADDED VALUE OF C-BUDDIES IN THE TREATMENT OF HEPATITIS C IN PERSONS WHO USE OR INJECT DRUGS Models of Care Abstract
142 Lauren Bradley IMPLEMENTING BEST PRACTICE MODELS OF CARE IN CUSTODIAL SETTINGS IN AUSTRALIA: WHAT ROLE DOES THE NATIONAL HEPATITIS C STRATEGY PLAY? Models of Care Abstract
143 Taha Brahni ISSUES OF ADHERENCE TO THE OPIOID SUBSTITUTION THERAPY IN THE NORTH OF MOROCCO Models of Care Abstract
144 Dana Busschots REACHING OUT TO THE UNDIAGNOSED PEOPLE WITH HEPATITIS C INFECTION IN BELGIUM Models of Care Abstract
145 Christopher Byrne TREATMENT OF HCV/HIV CO-INFECTION IN NHS TAYSIDE, SCOTLAND, 2001-2019 Models of Care Abstract
146 Hugo Armando Castro Cortes COMMUNITY-BASED APPROACH TO HEPATITIS C IN PEOPLE WHO INJECT DRUGS, IN PEREIRA, COLOMBIA. Models of Care Abstract
147 Chris Cavacuiti A CLOUD-BASED APPROACH TO HEPATITIS C CARE IN PATIENTS WITH SUBSTANCE USE Models of Care Abstract
148 Elizabeth Crock SCALING-UP FOR HEPATITIS C ELIMINATION – LESSONS FROM A SUCCESSFUL PARTNERSHIP BETWEEN AN HIV AND HOMELESSNESS NURSING PROGRAM AND AN HIV/AIDS SERVICE ORGANIZATION IN MELBOURNE, AUSTRALIA. Models of Care Abstract
149 Jina Devi LINKAGE TO HCV CARE AND TREATMENT AMONG PEOPLE WHO USE OR INJECT DRUG Models of Care Abstract
150 Joseph Doyle A NURSE-LED, COMMUNITY BASED MODEL OF HEPATITIS C CARE IN MELBOURNE, AUSTRALIA; 2017-2018 Models of Care Abstract
151 Sandra Dröse A MODEL OF CARE FOR PEOPLE ATTENDING DRUG TREATMENT CENTERS AIMING AT HEPATITIS C ELIMINATION BY 2022. A PART OF THE C- FREE SOUTH STRATEGY Models of Care Abstract
152 Colleen Flanigan AN INITIATIVE AIMED AT BUILDING CAPACITY IN HEALTHCARE ORGANIZATIONS TO PROVIDE STIGMA-FREE CARE TO PEOPLE WHO USE DRUGS. Models of Care Abstract
153 Marie-ève Goyer INTEGRATED AND LOW-THRESHOLD MODELS OF CARE IN OPIOID AGONIST TREATMENT CENTERS: ARE WE THERE YET IN QUÉBEC? Models of Care Abstract
154 Louise Hansford ACCESSING THE INACCESIBLE: AN INNOVATIVE APPROACH TO HEPATITIS C TESTING AND TREATMENT IN THE COMMUNITY Models of Care Abstract
155 Mamta Jain HEPATITIS C TREATMENT IN HIV PATIENTS: COMPARISON BETWEEN TREATMENT LIVER SPECIALTY VS. PRIMARY CARE Models of Care Abstract
156 Shashi Kapadia THE ROLE OF A HEPATITIS C CARE COORDINATOR IN PROVIDING COMPREHENSIVE CARE TO FACILITATE HEPATITIS C TREATMENT AMONG PEOPLE WHO INJECT DRUGS Models of Care Abstract
157 Dominique Larrey EFFICACY OF HCV INFECTION TREATMENT USING A “GO-TO-THE-PATIENT” ACTION AMONG PATIENTS NOT ATTENDING STANDARD MEDICAL CARE CENTRES WITH ACTIVE/ SUBSTITUED DRUG/ALCOHOL ADDICTION AND/OR HIGH SOCIAL PRECARIOUSNESS Models of Care Abstract
158 Yin Liu THE OPTIMAL STRATEGY OF HEPATITIS C THERAPY IN GENOTYPE 1B TREATMENT-NAÏVE PATIENTS WHO INJECT DRUGS IN CHINA: A DECISION AND COST-EFFECTIVENESS ANALYSIS Models of Care Abstract
159 Saveria Lory, Crocè “FIVE STEPS” INTO THE TRIESTE INTEGRATE MODEL FOR TREATMENT OF HEPATITIS C IN PEOPLE WHO INJECT DRUGS. Models of Care Abstract
160 Stéphanie Marsan USING THE PROJECT ECHO MODEL OF CARE TO INCREASE ACCESS TO ADDICTION MEDICINE SERVICES FOR FIRST NATIONS AND INUIT COMMUNITIES IN THE PROVINCE OF QUEBEC Models of Care Abstract
161 Cristiana Merendeiro HIV AND HCV SCREENINGS IN HARM REDUCTION SETTINGS - A PILOT PROJECT BASED ON A PROXIMITY STRATEGY Models of Care Abstract
162 Håvard Midgard THE HEPATITIS C CASCADE OF CARE AND TREATMENT OUTCOMES AMONG PEOPLE WHO INJECT DRUGS IN A NORWEGIAN LOW-THRESHOLD SETTING: A REAL LIFE EXPERIENCE Models of Care Abstract
163 Eithne Nic an Riogh THE HEPCARE MODEL OF INTEGRATED CARE IMPROVES CLINIC ATTENDANCE IN ‘HARD TO REACH’ HEPATITIS C POSITIVE PATIENTS Models of Care Abstract
164 Margaret O'sullivan PROJECT ITTREAT (INTEGRATED COMMUNITY BASED TEST – STAGE-TREAT HCV SERVICE) FOR PEOPLE WHO INJECT DRUGS: CLINICAL, PATIENT REPORTED AND HEALTH ECONOMIC OUTCOMES. Models of Care Abstract
165 Alisa Pedrana SUPPORTING PRIMARY CARE CLINICS TO PRIORITISE HEPATITIS C TESTING AND TREATMENT THROUGH THE PROVISION OF A TAILORED PACKAGE OF INTERVENTIONS – THE EC NURSE-LED MODEL Models of Care Abstract
166 Cláudia Pereira A PROXIMITY HARM REDUCTION APPROACH TO IMPROVE HCV TREATMENT ADHERENCE Models of Care Abstract
167 Chase Perfect ADDRESSING INSUFFICIENT HCV KNOWLEDGE AND SERVICE CAPACITY THROUGH COMMUNITY-LED TRAININGS ON HCV AND MARGINALIZED POPULATIONS’ NEEDS Models of Care Abstract
168 Philip Olesen APPLYING BEHAVIOURAL INTERVENTIONS TO INCREASE HCV SCREENING RATES IN COMMUNITY DRUG TREATMENT SETTINGS Abstract
169 Phillip Read ACCESSING HIDDEN POPULATIONS: AN EXTENDED OUTREACH SERVICE OF THE KIRKETON ROAD CENTRE Models of Care Abstract
170 Sarah Rowan VIRAL HEPATITIS TESTING AND LINKAGE TO CARE FOR INDIVIDUALS ENROLLED IN OPIOID TREATMENT PROGRAMS IN DENVER, COLORADO Models of Care Abstract
171 Andrew Scheibe VIRAL HEPATITIS C PREVALENCE, INCIDENCE, INJECTING PRACTICES AND LINKAGE TO CARE AMONG PEOPLE WHO INJECT DRUGS PARTICIPATING IN A METHADONE MAINTENANCE THERAPY PILOT PROJECT IN CAPE TOWN, SOUTH AFRICA. Models of Care Abstract
172 Kathleen Seneca NALTREXONE XR (XR-NTX) CAN BE USED TO SUPPORT HEPATITIS C VIRUS (HCV) TREATMENT IN YOUNG MEDICALLY WITHDRAWN PERSONS WHO INJECT DRUGS (PWIDS) – A PRELIMINARY REPORT Models of Care Abstract
173 Christian Sharkey IMAGE AND PERFORMANCE ENHANCING DRUGS, A RISK FOR HCV OR FATTY LIVER DISEASE? Models of Care Abstract
174 David Wicks ONSITE CASE MANAGEMENT- BRIDGING THE DIVIDE BETWEEN HCV DIAGNOSIS AND TREATMENT FOR PEOPLE WHO INJECT DRUGS. Models of Care Abstract
175 Marie Sutton A PERFECT STORM AND A PERFECT OPPORTUNITY: THE STORY OF AN INNOVATIVE HCV SCREENING AND LTC PROGRAM FOR SUBSTANCE USERS IN GEORGIA Models of Care Abstract
176 Jan Tait ACHIEVING HEPATITIS C ELIMINATION: A CHANGE IN A CARE PATHWAY WITHIN A PRISON INCREASES ACCESS TO HEPATITIS C TREATMENT. Models of Care Abstract
177 Effrosyni Tsirogianni MICRO-ELIMINATION OF HEPATITIS C AMONG INCARCERATED POPULATION: THE INTERVENTION ACCESS4ALL IN A LARGE PRISON OF THESSALONIKI, GREECE Models of Care Abstract
178 Megan Urry LOW THRESHOLD SERVICES FOR PWUD: INTEGRATING BUPRENORPHINE INTO A COMPREHENSIVE HIV, HCV AND SEXUAL HEALTH CARE AND TREATMENT PROGRAM IN NEW YORK CITY Models of Care Abstract
179 Claire Wartelle-bladou FIRST FRENCH-SPEAKING ECHO® HEPATITIS C TELEMENTORING PROGRAM: EVALUATION AT YEAR-TWO. Models of Care Abstract
180 Bradley Whitton INTEGRATING HEPATITIS C CARE WITH MENTAL HEALTH AND ALCOHOL AND OTHER DRUG SERVICES Models of Care Abstract
181 Cara Skillingstead EDUCATION TO REDUCE HIV/HBV/HCV TRANSMISSION IN INCARCERATED POPULATIONS Models of Care Abstract
182 Daniel Winetsky CHANGES IN HOUSING STABILITY AND TREATMENT FOR OPIOID USE DISORDER DURING HEPATITIS C TREATMENT AT A HARM REDUCTION PROGRAM Models of Care Abstract
183 Daniel Winetsky THE IMPACT OF PSYCHOSOCIAL FACTORS ON THE CARE CASCADE FOR HEPATITIS C TREATMENT AT A HARM REDUCTION PROGRAM Models of Care Abstract
184 Debbie Winwood MAPPING HEPATITIS C SERVICES TO REMOVE BARRIERS TO TREATMENT FOR PEOPLE WHO INJECT DRUGS Models of Care Abstract
185 Debbie Winwood WWW. WORKING WITHIN WALSALL TO ELIMINATE HEPATITIS C: FROM TEST TO CURE Models of Care Abstract
186 Alexander Wong AN ON-SITE NURSE-LED PROTOCOL-DRIVEN MODEL OF CARE IMPROVES ACCESS TO HCV TREATMENT FOR TRANSIENTLY INCARCERATED PERSONS IN A PROVINCIAL CORRECTIONAL FACILITY IN SASKATCHEWAN, CANADA Models of Care Abstract
187 Klaudia Zabrzenski THE ACE TEAM- AN INNER CITY OUTREACH TEAM FOR HIGH BARRIER HIV AND HEPATITIS C INDIVIDUALS Models of Care Abstract
188 Nicolas Clark TREATMENT OF HEPATITIS C IN A MEDICALLY SUPERVISED INJECTING ROOM: A MODEL FOCUSED ON REDUCING BARRIERS TO INITIATION
189 Jasna Cernosa STAGE OF LIVER FIBROSIS IN PEOPLE WHO INJECT DRUGS MANAGED AT LOW-THRESHOLD SETTINGS IN SLOVENIA: RESULTS OF A NATIONAL STUDY
190 Pascal Melin FEATURING SCREENING HEPATITIS C AND SOCIAL NETWORK MANY EX DRUG USERS AMONG ALCOOLIC POPULATION: SCREENING HEPATITIS C ON A FACEBOOK GROUP CALLED “MOIS SOBRE” Abstract
191 Mim O'Flynn WHAT DOES HCV CARE LOOK LIKE TO YOU?